Translational Development Acquisition Corp. (TDAC) at a glance
Translational Development Acquisition Corp. (TDAC) is a micro-cap Financial Services company. It trades at $10.84, with a P/E of 38.3 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Momentum (73/100) and its weakest is Growth (20/100).
- Price
- $10.84
- Market cap
- $234.8M
- P/E ratio
- 38.3
- Dividend yield
- None
- Beta
- n/a
- 52-week range
- $10.33 to $10.95
Value
43
Growth
20
Income
40
Safety
66
Momentum
73
Other Financial Services stocks
See allJPM68
JPMorgan Chase & Co.
$349.93+0.74%
1.84% yield
V62
Visa Inc. Class A
$370.93+0.39%
0.81% yield
MA59
Mastercard Incorporated
$568.43+0.52%
0.67% yield
BAC70
Bank of America Corporation
$58.01+1.86%
2.00% yield
MS66
Morgan Stanley
$203.00-0.28%
1.87% yield
HSBC53
HSBC Holdings plc Sponsored ADR
$100.86+0.65%
4.03% yield
GS64
The Goldman Sachs Group, Inc.
$940.60-0.74%
1.60% yield
WFC67
Wells Fargo & Company
$87.05+1.88%
2.15% yield